Barclays Begins Coverage on Oscar Health (NYSE:OSCR)

Equities researchers at Barclays assumed coverage on shares of Oscar Health (NYSE:OSCR - Get Free Report) in a note issued to investors on Wednesday, MarketBeat Ratings reports. The brokerage set an "underweight" rating and a $17.00 price target on the stock. Barclays's price target points to a potential upside of 2.91% from the stock's current price.

A number of other equities research analysts have also recently commented on the company. Raymond James Financial cut Oscar Health from an "outperform" rating to a "market perform" rating in a research note on Tuesday, June 24th. Piper Sandler cut their price objective on shares of Oscar Health from $25.00 to $18.00 and set an "overweight" rating on the stock in a research report on Monday, June 9th. Wall Street Zen lowered shares of Oscar Health from a "buy" rating to a "hold" rating in a research note on Sunday, June 8th. Finally, Wells Fargo & Company downgraded shares of Oscar Health from an "overweight" rating to an "equal weight" rating and dropped their target price for the stock from $20.00 to $16.00 in a research note on Thursday, March 13th. Three research analysts have rated the stock with a sell rating, four have given a hold rating and one has assigned a buy rating to the stock. According to MarketBeat, the company has an average rating of "Hold" and an average target price of $16.58.

Oscar Health Stock Down 0.6%

NYSE:OSCR traded down $0.10 during mid-day trading on Wednesday, hitting $16.52. 29,008,142 shares of the company's stock were exchanged, compared to its average volume of 6,275,183. The company has a market cap of $4.21 billion, a PE ratio of 59.00 and a beta of 1.90. The company has a debt-to-equity ratio of 0.22, a current ratio of 0.88 and a quick ratio of 0.88. Oscar Health has a one year low of $11.20 and a one year high of $23.79. The business has a fifty day moving average price of $16.02 and a 200 day moving average price of $14.81.

Oscar Health (NYSE:OSCR - Get Free Report) last issued its quarterly earnings results on Wednesday, May 7th. The company reported $0.92 EPS for the quarter, topping analysts' consensus estimates of $0.83 by $0.09. The firm had revenue of $3 billion for the quarter, compared to analysts' expectations of $2.87 billion. Oscar Health had a return on equity of 10.59% and a net margin of 1.22%. During the same period in the previous year, the firm posted $0.62 EPS. The business's revenue for the quarter was up 42.2% compared to the same quarter last year. Equities analysts predict that Oscar Health will post 0.69 EPS for the current year.

Insider Buying and Selling

In other Oscar Health news, Director Elbert O. Jr. Robinson sold 25,000 shares of the company's stock in a transaction dated Monday, May 12th. The shares were sold at an average price of $16.43, for a total transaction of $410,750.00. Following the transaction, the director owned 64,512 shares in the company, valued at approximately $1,059,932.16. This represents a 27.93% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Insiders own 24.39% of the company's stock.

Institutional Inflows and Outflows

Several hedge funds have recently made changes to their positions in the stock. Jones Financial Companies Lllp grew its holdings in shares of Oscar Health by 7,473.3% in the first quarter. Jones Financial Companies Lllp now owns 2,272 shares of the company's stock worth $30,000 after acquiring an additional 2,242 shares during the period. Strs Ohio bought a new stake in shares of Oscar Health during the 1st quarter valued at about $30,000. Larson Financial Group LLC lifted its stake in shares of Oscar Health by 83,733.3% in the 1st quarter. Larson Financial Group LLC now owns 2,515 shares of the company's stock worth $33,000 after purchasing an additional 2,512 shares during the period. CWM LLC grew its position in Oscar Health by 50.7% during the first quarter. CWM LLC now owns 3,204 shares of the company's stock valued at $42,000 after buying an additional 1,078 shares during the period. Finally, Caitong International Asset Management Co. Ltd increased its holdings in Oscar Health by 484.6% during the first quarter. Caitong International Asset Management Co. Ltd now owns 3,443 shares of the company's stock valued at $45,000 after buying an additional 2,854 shares during the last quarter. 75.70% of the stock is owned by hedge funds and other institutional investors.

Oscar Health Company Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.